Innovations in Biomedical Sensors to be a Prevalent Trend in Biomedical Sensors Market
According to our new market research study on “Biomedical Sensors Market to 2027 – COVID-19 Impact and Global Analysis – by Type, Sensor Type, Product, and Application,” the market is expected to reach US$ 35,982.7 million in 2027 from reach US$ 15,338.57 million in 2027 from US$ 8,688.63 million in 2019. The market is estimated to grow with at a CAGR of 7.4% from 2020 to -2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. The growth of the market is attributed to factors such as increase in geriatric population, rise in demand for home-based medical care, technological advancements in the medical device industry, rise in adoption of IoT-based medical devices, and increase in healthcare expenditure worldwide.
The growth of the market is attributed to factors such growing geriatric population, increasing demand for home-based medical care, technological advancements in the medical device industry, increasing adoption of IoT-based medical devices and rising expenditure on healthcare across the world.
Based on type, The the biomedical sensors market, by type, is segmented into wired and wireless. The wireless sensor segment held the largestr share of the market in 2019, and the same segment is anticipated to register the highest higher CAGR in the market during the forecast period.
The eRise inmerging applications of biomedical sensors in the field of nanotechnology and consistent innovations are leading to the development of innovative and advanced non-invasive sensor-based medical procedures, which are projected to fuel the market growth. Various companies are involved in the development of innovative applications of biomedical sensors applications. For instance, in February 2020, a research team at the UC San Diego Center developed a stretchy skin patch that combines electrochemical sensors for alcohol, caffeine, glucose, and lactate with an ultrasound-based sensor that monitors blood pressure deep inside the body. Moreover, iIn July 2020, a group of researchers at the University of Missouri have introduced a unique way of using graphite pencils and office paper to create highly functional bioelectronic devices. The team developed on-skin devices that can estimate body temperature, sense electrocardiography signals (ECG) signals, as well asand examine sweat for pH, glucose, and uric acid.
Various other next-generation biomedical sensors are mentioned below:
DNA Medical Institute (DMI) device is a portable, compact device that utilizes a single drop of blood to carry out hundreds of clinical lab tests, providing patients with gold-standard accuracy w.r.t.with respect to various problems ranging from common cold to Ebola.
Vital sign monitoring platform is a device that can be strapped to the upper arm. and It estimates various a patient’s data, such asincluding heart rate, temperature, blood oxygenation, movement and activity, and cutaneous blood perfusion and volume, on a daily basis.
Eigen LifeSciences XChallenge device enables blood test for Hepatitis B that can be examined in minutes with the help of the microprocessor on a smartphone. The test can pinpoint patients who need treatment the most; thus, allocating services where these are most required.
The clinical and product development engine has experienced profound disruption as colleagues adjust to remote work environments and lab capacity is reduced. Clinical trials are also severely affected by disruptions in both new enrollment and in keeping existing patients on therapies. The impact of COVID-19 has placed many biomedical sensor companies under pressure due to low sales and disruption in supply chainsThe impact of COVID-19 has placed many biomedical sensor companies under pressure. However, it also has had a positive impact on the medical devices industry, increasing the R&D activities, thereby leading to a rise in medical device assistance for the detection of COVID-19.
The clinical and product development engine has experienced profound disruption as colleagues adjust to remote work environments and lab capacity is reduced. Clinical trials are also severely affected by disruptions in both new enrollment and in keeping existing patients on therapies. The impact of COVID-19 has placed many biomedical sensors companies under pressure. However, it also has had a positive impact on the medical device industry, wherein the demand for R&D activity is increasing, leading to a rise in medical device assistance for the detection of COVID-19.
Analog Devices, Inc., .; GE Healthcare, ; STMicroelectronics, ; Honeywell International, : Medtronic, ; NXP Semiconductors N.V., .; Pinnacle Technology Inc., .; Sensirion AG, ; TE Connectivity, ; and Texas Instruments Incorporated. are among the leading companies in the biomedical sensors market.
By Sensor Type
- Image Sensor
- Inertial Sensor
- Motion Sensor
- Electrocardiogram (ECG)
- Other Sensor Types
- Invasive Sensors
- Non-Invasive Sensors
- Medical Diagnostics
- Clinical Therapy
- Personal Healthcare
Contact UsContact Person: Sameer Joshi Phone: +1-646-491-9876
- North America
- Asia Pacific (APAC)
- South Korea
- Middle East and & Africa (MEA)
- Saudi Arabia
- South Africa
- South and Central America (SCAM)
Email Id: firstname.lastname@example.org